AstraZeneca, Daiichi drug boosts survival in aggressive breast cancer
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said their drug Datroway significantly improved survival outcomes for patients with a hard-to-treat form of breast cancer, marking a potential advance in treatment options. Read More